As healthcare infrastructure continues to modernize globally, distributor hematology analyzer networks and biochemical analyzer distribution channels have become essential for ensuring the availability, accessibility, and reliability of advanced laboratory diagnostic technologies, where the increasing prevalence of chronic diseases, infectious cond